A Study of JNJ-77474462 (Bermekimab) in Healthy Participants of Japanese Descent Following Administration of Single Ascending Subcutaneous Doses
Clinical trial NCT04544826 · COMPLETED
Trial details
- NCT number
- NCT04544826
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-16
- Primary completion
- 2021-08-05
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.